These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7367849)

  • 1. [Initial aspects of the changes in diabetic proteinuria].
    de Seigneux R; Schwarz R; Balant L; Fabre J
    Schweiz Med Wochenschr; 1980 Feb; 110(8):295-301. PubMed ID: 7367849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proteinuria in mature diabetic patients. Quantitative and qualitative analysis].
    Ducrey J; Fabre J; Balant L; Leblanc A; Duvivier E
    Schweiz Med Wochenschr; 1975 Sep; 105(36):1138-44. PubMed ID: 1215895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value and limits of urinary protein electrophoresis with sodium dodecyl sulfate in the evaluation of glomerular nephropathies].
    Galli R; Chavaz A; Balant L; Chatelanat F; Fabre J
    Schweiz Med Wochenschr; 1979 Jun; 109(23):874-80. PubMed ID: 451509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physiological proteinuria. Data of acrylamide-SDS gel electrophoresis and other methods of qualitative and quantitative analysis].
    Cao A; Balant L; Fabre J; Canavèse JC
    Schweiz Med Wochenschr; 1975 Apr; 105(14):421-9. PubMed ID: 1124369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of microproteinuria in patients with diabetes mellitus].
    Ishii K; Koyama A; Kobayahsi M; Itakura M; Kawai K; Yamashita K; Narita M
    Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):815-25. PubMed ID: 2593318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of different electrophoretic methods for the analysis of urinary proteins.
    Balant L; Fabre J
    Curr Probl Clin Biochem; 1979; (9):216-34. PubMed ID: 446073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of polyacrylamide gel electrophoresis-SDS to the study of proteinuria (author's transl)].
    Cachera C; Mizon C; Fruchart JC; Mizon J; Tacquet A
    Ann Biol Clin (Paris); 1978; 36(1):27-32. PubMed ID: 686517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Findings on proteinuria in selected diabetic patients. Relation to microangiopathy and its prognostic significance].
    Scaroina F; Martino P; Gai M
    Minerva Med; 1981 Mar; 72(9):561-8. PubMed ID: 7243041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non diabetic renal disease in type 2 diabetes mellitus.
    Soni SS; Gowrishankar S; Kishan AG; Raman A
    Nephrology (Carlton); 2006 Dec; 11(6):533-7. PubMed ID: 17199793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible tubular proteinuria associated with hyperglycemic ketoacidosis in type 1 diabetes mellitus.
    Miltényi M; Körner A; Dobos M; Tichy M
    Int J Pediatr Nephrol; 1983 Dec; 4(4):247-50. PubMed ID: 6420364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of urinary protein in diabetics; its clinical implications as a predictor of nephropathy.
    Suenaga K
    Nihon Jinzo Gakkai Shi; 1991 Jan; 33(1):43-52. PubMed ID: 2038131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise induced proteinuria as an early indicator of diabetic nephropathy.
    Agarwal RP; Thanvi I; Vachhani G; Kochar DK; Rastogi A
    J Assoc Physicians India; 1998 Sep; 46(9):772-4. PubMed ID: 11229244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pre-occupying increase in diabetes as cause for terminal kidney failure. Evaluation of treatment strategies].
    Pérez García R; Rodríguez Benítez P; Dall'Anesse C; Gómez Campderá F; Valderrábano F
    An Med Interna; 2001 Apr; 18(4):175-80. PubMed ID: 11496535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heterogeneity of causes of proteinuria in patients with non-insulin dependent diabetes mellitus].
    Gordeev AV; Peskov DIu
    Ter Arkh; 2001; 73(6):51-4. PubMed ID: 11521524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetic proteinuria. Statistical study (author's transl)].
    Glandier Y; Champeyroux J; Moinade S
    Sem Hop; 1980 Nov 18-25; 56(43-44):1833-6. PubMed ID: 6256887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
    Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
    Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P; Eiam-Ong S; Suwanwalaikorn S
    J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unchanged incidence of diabetic nephropathy in Type 1 diabetes: a nation-wide study in Iceland.
    Tryggvason G; Indridason OS; Thorsson AV; Hreidarsson AB; Palsson R
    Diabet Med; 2005 Feb; 22(2):182-7. PubMed ID: 15660736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic.
    Al-Wakeel JS; Hammad D; Al Suwaida A; Mitwalli AH; Memon NA; Sulimani F
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):77-85. PubMed ID: 19112222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
    Cha DR; Kim IS; Kang YS; Han SY; Han KH; Shin C; Ji YH; Kim NH
    Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.